Document Detail


Blood pressure- and pulse pressure-lowering effects, trough:peak ratio and smoothness index of telmisartan compared with lisinopril.
MedLine Citation:
PMID:  14508234     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To compare lisinopril with telmisartan, in regard to: 1) their effect on blood pressure (BP) and pulse pressure (PP), and 2) the duration and the homogeneity of their antihypertensive effect. PATIENTS AND METHODS: A randomized, open-label, crossover, comparative study of telmisartan 80 mg versus lisinopril 20 mg was conducted in 32 untreated hypertensive patients using clinic and 24-hour ambulatory BP measurements. Trough: peak ratio (TPR) and smoothness index (SI) were calculated for each drug. RESULTS: Using both measurement techniques no difference was detected between the 2 drugs in their effects either on BP (mean difference in 24-hour systolic BP 1.2 +/- 7.1 mm Hg, 95% confidence intervals -1.4, 3.8, and diastolic 0.7 +/- 5.1, -1.2, 2.5) or on PP (0.5 +/- 3.5, -0.7, 1.8). There was no difference between the TPR and the SI values of telmisartan (TPR 0.85/0.61 for systolic/diastolic BP and SI 1.46/1.2) and lisinopril (TPR 0.74/0.64 and SI 1.3/1.17). CONCLUSIONS: These data suggest that telmisartan is as effective as lisinopril in reducing BP and PP. Both drugs seem to provide smooth and sustained effects throughout the full 24-hour period.
Authors:
George S Stergiou; Stamatis P Efstathiou; Leonidas G Roussias; Theodore D Mountokalakis
Related Documents :
16805884 - Management of hypertension in hemodialysis patients.
16368314 - Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitor...
19404314 - Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and respon...
3759424 - Overestimation of blood pressure in the elderly.
7592214 - Lung tissue distortion in response to methacholine in rats: effect of lung volume.
18936344 - Patients with renal dysfunction require a longer duration until blood pressure dips dur...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  42     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-09-25     Completed Date:  2004-03-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  491-6     Citation Subset:  IM    
Affiliation:
Third University Department of Medicine, Sotiria Hosptial, Athens, Greece. gstergi@med.uoa.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Benzimidazoles / administration & dosage,  pharmacokinetics*,  therapeutic use
Benzoates / administration & dosage,  pharmacokinetics*,  therapeutic use
Blood Pressure / drug effects*
Blood Pressure Monitoring, Ambulatory*
Cross-Over Studies
Humans
Hypertension / drug therapy,  physiopathology
Lisinopril / administration & dosage,  pharmacokinetics*,  therapeutic use
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Benzimidazoles; 0/Benzoates; 144701-48-4/telmisartan; 83915-83-7/Lisinopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA...
Next Document:  Impaired nitric oxide function in the basilar artery of the obese Zucker rat.